| miR-126–5p |
Aβ1–42 |
regulates growth
factor
activities in neurons |
(41) |
| miR-145-5p |
Aβ1–42 |
targeting of TRIM2 mediates
the apoptosis of retinal ganglion cells via the PI3K/AKT signaling pathway |
(42) |
| miR-181a-2–3p |
Aβ1–42 |
targets RyanR3, which mediates
the release of calcium from the endoplasmic reticulum, and a dysregulation
of this process has been described as linked to synaptic loss and
impaired cognitive function in AD |
(40) |
| miR-194–5p |
Aβ1–42 |
accelerates apoptosis
of Aβ1–42-transduced hippocampal
neurons
by inhibiting Nrn1 and decreasing PI3K/Akt signaling pathway activity |
(43) |
| miR-3177–3p |
Aβ1–42 and P-tau181 |
|
|
| miR-323a-3p |
Aβ1–42 |
may regulate amyloid
precursor
protein expression under physiological and pathological conditions |
(44) |
| miR-342–5p |
Aβ1–42 |
decreases ankyrin G levels |
(45) |
| miR-22–3p |
P-tau181 |
regulates Aβ1–42 deposit by targeting mitogen-activated protein kinase 14 |
(46) |
| miR-30e-5p |
P-tau181 |
regulates neuroinflammation
by targeting Nlrp3 |
(47) |
| miR-340–3p |
P-tau181 |
reduces the accumulation
of Aβ through targeting BACE1 |
(48) |
| miR-374b-5p |
P-tau181 |
deregulated lncRNA MAGI2-AS3 sponges miR-374b-5p attenuates Aβ induced neurotoxicity and neuroinflammation |
(49) |
| miR-494–3p |
P-tau181 |
reduces DJ-1 expression
and exacerbates neurodegeneration |
(50) |